Ask the doctor: Should I try one of the new blood thinners?

Although new blood thinners such as dabigatran (Pradaxa) and rivaroxaban (Xarelto) do not require regular monitoring, people who manage well on warfarin may want to stay on warfarin until additional information on these new drugs becomes available.

Content restricted. Requires subscription

Heart Advances from Harvard: Overall health may determine survival after cardiac arrest

The health of a person with a sudden cardiac arrest who is admitted to a hospital through the emergency department may be as important to the outcome as the quality of care the person receives.

Content restricted. Requires subscription